Cargando…

Amphotericin B May Decrease the Serum Level of Voriconazole: A Case Report and Brief Review of Literature

BACKGROUND: Combination therapy with amphotericin B (AmB) and Voriconazole are sometimes used due to reducing AmB-related adverse reactions and improving outcomes. However, there was no report whether AmB would affect the serum level of Voriconazole. CASE PRESENTATION: A patient was in presumption o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Zhen, Zhou, Huaying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9480596/ https://www.ncbi.nlm.nih.gov/pubmed/36119639 http://dx.doi.org/10.2147/IDR.S374853

Ejemplares similares

Amphotericin-B-liposomal/voriconazole: Renal impairment: case report
Publicado: (2021)

Efficacy of voriconazole and amphotericin B in corneal preservative media
por: Das, Sujata, et al.
Publicado: (2022)

Amphotericin-B-liposomal/isavuconazole/voriconazole: Lack of efficacy: 6 case report
Publicado: (2022)

Successful Treatment of Disseminated Fusariosis with the Combination of Voriconazole and Liposomal Amphotericin B
por: Efe İris, Nur, et al.
Publicado: (2016)

Amphotericin-B liposomal/voriconazole: Drug induced liver injury and hypokalaemia: case report
Publicado: (2021)

Amphotericin-b/dexamethasone/voriconazole: Palatal mucormycosis, neutropenia and electrolyte disturbance: 2 case reports
Publicado: (2022)

Amphotericin-B-liposomal/prednisone/voriconazole: Photosensitivity, cicatricial ectropion and lack of efficacy: case report
Publicado: (2022)

Refractory Scedosporium apiospermum Keratitis Successfully Treated with Combination of Amphotericin B and Voriconazole
por: Fadzillah, Mohd-Tahir, et al.
Publicado: (2013)

Filamentous fungal endophthalmitis: results of combination therapy with intravitreal amphotericin B and voriconazole
por: Mithal, Kopal, et al.
Publicado: (2015)

Effective Voriconazole in an Immunocompetent Patient With Amphotericin B Resistant Systemic Cryptococcal Granulomatosis
por: Serraj, Khalid, et al.
Publicado: (2020)

Antifungal wound penetration of amphotericin and voriconazole in combat-related injuries: case report
por: Akers, Kevin S, et al.
Publicado: (2015)

Voriconazole or Amphotericin B as Primary Therapy Yields Distinct Early Serum Galactomannan Trends Related to Outcomes in Invasive Aspergillosis
por: Chai, Louis Yi Ann, et al.
Publicado: (2014)

Effect of amphotericin B and voriconazole on the outgrowth of conidia of Aspergillus fumigatus followed by time-lapse microscopy
por: Talas, Laszlo, et al.
Publicado: (2019)

Predictive Nephrotoxicity Profiling of a Novel Antifungal Small Molecule in Comparison to Amphotericin B and Voriconazole
por: Udawatte, Nadeeka S., et al.
Publicado: (2020)

2105. Liposomal Amphotericin B Use Before and After Implementation of Voriconazole Prophylaxis in Cancer Patients
por: Shams, Madeeha, et al.
Publicado: (2019)

850. Real-world effectiveness and safety compared among isavuconazole, amphotericin B, and voriconazole in invasive mold disease patients
por: Qiu, Ye, et al.
Publicado: (2023)

Pharmacoeconomic evaluation of voriconazole vs. liposomal amphotericin B in empiric treatment of invasive fungal infections in Turkey
por: Turner, Stuart J, et al.
Publicado: (2013)

Serum voriconazole level variability in patients with hematological malignancies receiving voriconazole therapy
por: Saini, Lalit, et al.
Publicado: (2014)

3,5-Dicaffeoylquinic Acid Disperses Aspergillus Fumigatus Biofilm and Enhances Fungicidal Efficacy of Voriconazole and Amphotericin B
por: Luo, Jing, et al.
Publicado: (2018)

Antifungal Susceptibility to Amphotericin B, Fluconazole, Voriconazole, and Flucytosine in Candida Bloodstream Isolates from 15 Tertiary Hospitals in Korea
por: Jung, Sook-In, et al.
Publicado: (2012)

Voriconazole-Induced Hepatotoxicity Resolved after Switching to Amphotericin B in Fusarium dimerum Central Line-Associated Bloodstream Infection
por: Alshaya, Omar A., et al.
Publicado: (2021)

Decrease of voriconazole trough levels during therapy with enteral nutrition: a case report
por: Kaneko, Hiromi, et al.
Publicado: (2022)

In vitro susceptibility to amphotericin B, itraconazole, voriconazole, posaconazole and caspofungin of Aspergillus spp. isolated from patients with haematological malignancies in Tunisia
por: Gheith, Soukeina, et al.
Publicado: (2014)

Successful Treatment of Antifungal Combination Therapy with Inhaled Liposomal Amphotericin B and Oral Voriconazole for Intractable Chronic Progressive Pulmonary Aspergillosis
por: Hamada, Noboru, et al.
Publicado: (2021)

Pharmacodynamic and immunological interactions of amphotericin B formulations and voriconazole with human neutrophils against mature Scedosporium apiospermum and Fusarium spp. biofilms
por: Vikelouda, Katerina, et al.
Publicado: (2023)

Efficacy and Safety of Voriconazole Versus Amphotericin B Deoxycholate Induction Treatment for HIV-Associated Talaromycosis: A Prospective Multicenter Cohort Study in China
por: Zhou, Yihong, et al.
Publicado: (2022)

Amphotericin-B/amphotericin-B-liposomal: Lack of efficacy: 2 case reports
Publicado: (2022)

Cost analysis of voriconazole versus liposomal amphotericin B for primary therapy of invasive aspergillosis among patients with haematological disorders in Germany and Spain
por: Ostermann, Helmut, et al.
Publicado: (2014)

Trichosporon faecale invasive infection in a patient with severe aplastic anemia: Efficacy of voriconazole and liposomal amphotericin B before neutrophil recovery
por: Pérard, Baptiste, et al.
Publicado: (2015)

Cost-effectiveness analysis of voriconazole, fluconazole, and amphotericin B for invasive fungal infections following allogeneic hematopoietic stem cell transplantation in Mexico
por: Morfín-Otero, Rayo, et al.
Publicado: (2018)

Comparison of Safety and Efficacy of Intrastromal Injections of Voriconazole, Amphotericin B and Natamycin in Cases of Recalcitrant Fungal Keratitis: A Randomized Controlled Trial
por: Saluja, Gunjan, et al.
Publicado: (2021)

Amphotericin B plus fluorocytosine combined with voriconazole for the treatment of non-HIV and non-transplant-associated cryptococcal meningitis: a retrospective study
por: Liu, Junyu, et al.
Publicado: (2022)

Comparing Invasive Pulmonary Aspergillosis Mortality Between Liposomal Amphotericin B and Voriconazole in Patients With Hematological Malignancy or Hematopoietic Stem Cell Transplantation
por: Mahmoud, Ebrahim, et al.
Publicado: (2022)

Treatment of a Locally Invasive Cutaneous Fusarium Species Infection With Voriconazole and Liposomal Amphotericin B in a Patient With Relapsed Acute Myeloid Leukemia
por: Meyer, Sara Anne, et al.
Publicado: (2017)

Voriconazole-Induced Photosensitivity in Children: A Case Report and Literature Review
por: Abdel-Haq, Nahed, et al.
Publicado: (2014)

Antifungal activity of amphotericin B and voriconazole against the biofilms and biofilm-dispersed cells of Candida albicans employing a newly developed in vitro pharmacokinetic model
por: El-Azizi, Mohamed, et al.
Publicado: (2015)

1639. Efficacy of Voriconazole Prophylaxis Followed by Therapeutic Liposomal Amphotericin B for the Treatment of Murine Pulmonary Aspergillosis Caused by Azole-Resistant Aspergillus fumigatus Strains
por: Olson, Jon, et al.
Publicado: (2018)

An Amphotericin B Derivative Equally Potent to Amphotericin B and with Increased Safety
por: Antillón, Armando, et al.
Publicado: (2016)

Encochleated Amphotericin B: Is the Oral Availability of Amphotericin B Finally Reached?
por: Aigner, Maria, et al.
Publicado: (2020)

Amphotericin B liposome-induced acrocyanosis and elevated serum creatinine
por: Zhang, Xiangcai, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_qglgupisv74vfqcaeq89r88mqh